SpiroChem AG is a Swiss fine chemicals company headquartered in Basel, Switzerland. As a global CRO (Contract Research Organization) and an innovative partner for Chemistry synthesis, SpiroChem AG specializes in providing tailor-made molecules and accelerating drug discovery. With cutting-edge know-how in drug design and proprietary process chemistry technologies, SpiroChem AG offers innovative chemical solutions to universities, biotechs, pharmaceutical, and agrochemical companies of all sizes.

Their services and products, including libraries, SpiroKits, and catalog compounds, are designed to help scientists accelerate drug discovery, improve ADME properties, explore novel chemical space, remove synthetic hurdles, and anticipate drug attrition. SpiroChem's mission is to accelerate projects and help clients reach their goals by providing the tools and expertise needed to advance medicinal chemistry programs. They have a team of leading scientists with over 150 years of combined experience in chemistry, working in academic and industrial settings.

SpiroChem AG has been recognized for their exceptional work, receiving industry prizes and awards, including the EFMC Prize for young Medicinal Chemist in Industry and the IMD-Start-up award. They also have ongoing collaborations with academia and technology companies worldwide, ensuring the continuous development of their products and services. With their innovative and rapid solutions, SpiroChem AG is committed to making their clients' projects a success and becoming their trusted solution provider